CD4 and neoplasm: CD4+ T cells are upstream activators of adaptive immunity, and their direct activation and targeting of the tumor antigens can initiate a robust antitumor immune response in cold tumors, which include early epithelial cancer and precancerous lesions (Kennedy and Celis, 2008).